Journal
NATURE CELL BIOLOGY
Volume 10, Issue 9, Pages 1098-1105Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1770
Keywords
-
Categories
Funding
- AICR
- AVENIR/INSERM
- La Ligue Contre le Cancer
- Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BD/16697/2004]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/16697/2004] Funding Source: FCT
Ask authors/readers for more resources
The E3 ubiquitin ligase Mdm2 is a focal regulator of p53 tumour suppressor activity. It binds p53, promoting its polyubiquitination and degradation, and also controls p53 synthesis. However, it is not known how this dual function of Mdm2 on p53 synthesis and degradation is achieved. Here we show that the p53 mRNA region encoding the Mdm2-binding site interacts directly with the RING domain of Mdm2. This impairs the E3 ligase activity of Mdm2 and promotes p53 mRNA translation. We also show that introduction of cancer-derived single silent point-mutations in the p53 mRNA weakens its binding to Mdm2 and results in reduced p53 activity. These data are consistent with a mechanism by which changes in silent nucleotides can affect the function of the encoded protein, and indicate that Mdm2-mediated control of p53 synthesis and degradation has evolved in the p53 mRNA sequence and its encoded amino acids.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available